AngioDynamics stock is undervalued, with Med Tech growth in thrombus management and atherectomy. Learn more about the company ...
CPT I code for NanoKnife prostate procedures is set to take effect on January 1, with management expecting incremental, ...
Medical experts warn that long periods of sitting during road trips or flights can significantly raise the risk of developing ...
Ephraim McDowell Regional Medical Center (EMRMC) has been designated a Silver Level Center on the Pathway to Excellence in ...
Boston Scientific Corporation is rated a Hold with double-digit revenue growth and margin expansion. Learn more about BSX stock here.
Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...
AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, ...
Nottinghamshire Live on MSN
All the times Nottinghamshire hospitals were told to do better by coroners in 2025
Nottinghamshire's coroners have shared their concerns about the county's hospital trusts on nine occasions in 2025, calling ...
Q2 2026 Earnings Call Transcript January 6, 2026 AngioDynamics, Inc. misses on earnings expectations. Reported EPS is ...
Mechanical thrombectomy (MT) is safe and effective in real-world, high-risk patients with pulmonary embolism (PE), according to a study published online Oct. 31 in the Journal of the Society for ...
In 2025, the medtech industry saw another year full of all kinds of deals in the mergers and acquisitions (M&A) arena.
The risk of developing a severe PE during short flights remains extremely low, because it occurs only once per million ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback